Cancer Immunology Research Program Seminar: "SBT6050: A HER2-Directed TLR8 Agonist Antibody Conjugate for Potent, Tumor-Localized Activation of Myeloid Cells"
Speaker
Silverback Therapeutics
Valerie Odegard, PhDPresident and Chief Scientific Officer
Hosts
Admission
Free
Tag
Lectures and Seminars